Press
EpiVax receives $150,000 in phase II funding from Slater Center for Bio-Technology
Posted on March 25, 2003 by epivax3EpiVax receives $150,000 in phase II funding from Slater Center for Bio-TechnologyRead moreEpiVax signs Master Services Agreement with Brown University
Posted on March 20, 2003 by epivax3EpiVax signs Master Services Agreement with Brown UniversityRead moreEpiVax signs Laboratory Services Agreement with Eli Lilly
Posted on March 25, 2002 by epivax3EpiVax signs Laboratory Services Agreement with Eli LillyRead moreAwarded SBIR Phase I grant for West Nile Virus diagnostic project
Posted on September 25, 2001 by epivax3Awarded SBIR Phase I grant for West Nile Virus diagnostic projectRead moreAwarded SBIR Phase I grant for Human Papiloma Virus vaccine project
Posted on September 20, 2001 by epivax3Awarded SBIR Phase I grant for Human Papiloma Virus vaccine projectRead moreSigned strategic cooperation and co-marketing agreement with Beckman Coulter Immunomics
Posted on June 25, 2001 by epivax3Signed strategic cooperation and co-marketing agreement with Beckman Coulter ImmunomicsRead moreAnne De Groot named Core Scientist by Sequella Global TB Foundation and awarded 3 year $900,000 TB vaccine development grant
Posted on April 25, 2000 by epivax3Anne De Groot named Core Scientist by Sequella Global TB Foundation and awarded 3 year $900,000 TB vaccine development grantRead moreAwarded SBIR Phase I for HIV vaccine development. Full time operations begin.
Posted on September 25, 1999 by epivax3Awarded SBIR Phase I for HIV vaccine development. Full time operations begin.Read moreAwarded phase 1 development grant from Rhode Island’s Slater Center for Biomedical Technology
Posted on June 25, 1998 by epivax3Awarded phase 1 development grant from Rhode Island’s Slater Center for Biomedical TechnologyRead moreEpiVax, Inc. founded by Dr. Anne De Groot
Posted on May 25, 1998 by epivax3EpiVax, Inc. founded by Dr. Anne De GrootRead more
Join our newsletter
We strive to provide our clients, collaborators and everyday immunology enthusiasts with valuable content. Written by our CEO/CSO Dr. Anne Dr Groot, you can expect up to date vaccine development efforts, upcoming events and so much more from our offices here in Providence, RI.